HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Biolimus A9

sirolimus derivative from a biodegradable polylactic acid polymer; possesses enhanced anti-inflammatory and antiproliferative activity with an improved pharmacokinetic profile; structure in first source
Networked: 5 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Christians, Uwe: 2 articles (04/2011 - 12/2008)
2. Sagic, Dragan: 2 articles (04/2011 - 12/2008)
3. Jung, Robert: 2 articles (04/2011 - 12/2008)
4. Zhang, Yan-Ling: 2 articles (04/2011 - 12/2008)
5. Paunovic, Dragica: 2 articles (06/2009 - 12/2008)
6. Corti, R: 1 article (12/2012)
7. Ueda, Yasunori: 1 article (01/2012)
8. Nakamura, Masato: 1 article (01/2012)
9. Mitsudo, Kazuaki: 1 article (01/2012)
10. Otsuka, Yoritaka: 1 article (01/2012)

Related Diseases

1. Coronary Artery Disease (Coronary Atherosclerosis)
2. Neointima
3. Acute Coronary Syndrome
4. Thrombosis (Thrombus)
5. Myocardial Infarction

Related Drugs and Biologics

1. Polymers
2. Sirolimus (Rapamycin)
3. poly(lactic acid) (polylactic acid)
4. glucuronyl glucosamine glycan sulfate (Vessel)

Related Therapies and Procedures

1. Stents